NCT02574728
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02574728
Title Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Acronym AflacST1502
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Phoenix Children's Hospital Phoenix Arizona 85016 United States Details
Nemours/Alfred I. duPont Hospital for Children Wilmington Delaware 19803 United States Details
Children's Healthcare of Atlanta-Egleston Atlanta Georgia 30322 United States Details
Children's Healthcare of Atlanta, Scottish Rite Atlanta Georgia 30342 United States Details
Children's Mercy Hospital Kansas City Missouri 64108 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field